Restricted accessLetterFirst published online 2017-07
Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend
NimriR, MullerI, AtlasE, et al.: MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care, 2014; 37:3025–3032.
2.
HovorkaR, ElleriD, ThabitH, et al.: Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care, 2014; 37:1204–1211.
3.
SharifiA, De BockMI, JayawardeneD, et al.: Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed- loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study. Diabetes Technol Ther, 2016; 18:772–783.
4.
The Performance of an Artificial Pancreas at Home in People With Type 1 Diabetes. https://clinicaltrials.gov/ct2/show/NCT02040571 (accessed January15, 2017).
5.
GenterP, BermanN, JacobM, et al.: Counterregulatory hormones oscillate during steady-state hypoglycemia. Am J Physiol, 1998; 275:821–829.
6.
LingenfelserT, RennW, SommerwerckU, et al.: Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes, 1993; 42:610–618.
7.
Dagogo-JackSE, CraftS, CryerPE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest, 1993; 91:819–828.
